Rare diseases
Investigational molecules
Locations
Back to Germany8 clinical trials in Eisenach, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)A Phase III Randomized Double‑Blind Study of Elecoglipron for Adults with Type 2 Diabetes on Insulin
GermanyStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
GermanyStudy on Acalabrutinib, Obinutuzumab, and Venetoclax for Untreated High-Risk Chronic Lymphocytic Leukemia Patients
GermanyComparison of weekly insulin icodec versus daily basal insulin in adults with type 2 diabetes who have not used insulin before
GermanyEvaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk
GermanyComparing weekly insulin icodec and daily insulin glargine with insulin aspart in adults with type 1 diabetes: a 26-week study of blood sugar control
GermanyStudy on Adjuvant Therapy with Capecitabine for Stage II Colon and Rectal Cancer Patients with Positive ctDNA After Tumor Removal
GermanyEvaluating Once Daily Orforglipron (LY3502970) Compared to Insulin Glargine in Adults with Type 2 Diabetes and Obesity or Overweight who Have Increased Cardiovascular Risk
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Type 2 Diabetes management, comparing advanced therapeutic options for patients with cardiovascular risk factors. Studies are evaluating new treatments that could offer improved glycemic control.
These trials aim to enhance treatment outcomes for patients with multiple metabolic conditions.
Groundbreaking studies in colon cancer treatment, particularly focusing on stage II patients. Research includes evaluation of circulating tumor DNA to guide adjuvant therapy decisions.
The research aims to improve treatment precision and patient outcomes.
Advanced research in Chronic Lymphocytic Leukemia, examining novel combination therapies for high-risk patients. Studies focus on improving progression-free survival through targeted treatment approaches.
These trials represent cutting-edge approaches in blood cancer treatment.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
